This is a StreetInsider.com Premium Only Page

Haemonetics (HAE) – PRNewswire

Apr 10, 2024 04:58 PM Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024

Apr 4, 2024 06:30 AM Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge

Apr 1, 2024 08:00 AM Haemonetics Corporation Completes Acquisition of Attune Medical

Mar 5, 2024 06:00 AM Haemonetics Announces Definitive Agreement to Acquire Attune Medical

Feb 21, 2024 05:57 PM Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference

Feb 21, 2024 05:55 PM Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

Feb 8, 2024 06:00 AM Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Jan 11, 2024 04:05 PM Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024

Dec 12, 2023 06:00 AM Haemonetics Corporation Completes Acquisition of OpSens Inc.

Dec 7, 2023 04:05 PM Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Nov 2, 2023 06:00 AM Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Oct 10, 2023 06:00 AM Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.

Oct 5, 2023 04:05 PM Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023

Aug 29, 2023 06:30 AM Haemonetics Announces European Expansion for VASCADE® Vascular Closure System

Aug 8, 2023 06:00 AM Haemonetics 1st Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Aug 7, 2023 04:10 PM Diane M. Bryant Joins Haemonetics' Board of Directors

Jul 10, 2023 04:05 PM Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2024 Results: August 8, 2023

Jul 10, 2023 04:05 PM /C O R R E C T I O N -- Haemonetics Corporation/

Jun 22, 2023 06:15 AM Haemonetics Receives FDA Clearance for Enhancements to NexSys PCS® Plasma Collection System

May 11, 2023 06:00 AM Haemonetics 4th Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

Apr 25, 2023 04:15 PM Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023

Apr 20, 2023 06:40 AM Haemonetics Publishes Inaugural Corporate Responsibility Report

Mar 2, 2023 06:35 AM Haemonetics Introduces Next Generation "Intelligent Control" Software for Cell Saver® Elite®+ Autotransfusion System

Feb 27, 2023 04:05 PM Haemonetics to Present at Raymond James 44th Annual Institutional Investors Conference

Feb 7, 2023 06:00 AM Haemonetics 3rd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

Jan 6, 2023 04:05 PM Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2023 Results: February 7, 2023

Dec 19, 2022 04:05 PM Haemonetics to Present at 41st Annual J.P. Morgan Healthcare Conference

Nov 7, 2022 06:00 AM Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

Oct 6, 2022 04:05 PM Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022

Oct 4, 2022 06:51 AM Haemonetics Appoints Roy Galvin as President, Global Plasma and Blood Center

Sep 12, 2022 06:45 AM Haemonetics Earns CE Mark for VASCADE® Vascular Closure Product Portfolio

Aug 29, 2022 04:11 PM Haemonetics Announces Agreement to Offer Enhanced Transfusion Management Software to Epic's Global Network of Hospitals

Aug 23, 2022 06:06 PM Haemonetics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Aug 10, 2022 06:00 AM Haemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

Jul 7, 2022 04:05 PM Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2023 Results: August 10, 2022

Jun 24, 2022 06:45 AM Haemonetics Completes Move to New Manufacturing Facility in Clinton, PA

Jun 6, 2022 06:00 AM Haemonetics Corporation Announces Additional Information Regarding Its Investor Day on June 29, 2022

May 10, 2022 06:00 AM Haemonetics to Host Investor Day Event on June 29, 2022

May 10, 2022 06:00 AM Haemonetics 4th Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Apr 6, 2022 04:05 PM Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2022 Results: May 10, 2022

Mar 21, 2022 04:35 PM Haemonetics Appoints James D'Arecca Chief Financial Officer

Feb 23, 2022 04:05 PM Haemonetics to Present at Raymond James 43rd Annual Institutional Investors Conference

Feb 8, 2022 06:00 AM Haemonetics 3rd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Jan 5, 2022 08:00 AM Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2022 Results: February 8, 2022

Nov 9, 2021 06:00 AM Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Nov 9, 2021 06:00 AM Haemonetics Announces CFO William P. Burke's Retirement for June 2022

Oct 6, 2021 04:10 PM Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2022 Results: November 9, 2021

Sep 30, 2021 04:11 PM Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation

Aug 25, 2021 08:52 AM Haemonetics To Present At The 19th Annual Morgan Stanley Global Healthcare Conference

Aug 11, 2021 06:00 AM Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website